Back to Nantahala Capital Management, LLC

Nantahala Capital Management, LLC

All holdings · as of Dec 31, 2025

133 positions

CompanyClassValueShares% of portfolio
Surrozen, Inc./DESRZNCommon Stock$5.19M229,5270.3%
ASSERTIO HOLDINGS INC$5.33M587,3350.3%
Unicycive Therapeutics, Inc.$5.42M939,2020.3%
InspireMD, Inc.NSPRCommon Stock$6.01M3,376,4840.4%
TELA Bio, Inc.$6.03M5,111,5880.4%
CENTESSA PHARMACEUTICALS PLC$6.37M254,8030.4%
DarioHealth Corp.DRIOCommon Stock$6.41M563,2320.4%
Codexis, Inc.$6.50M3,990,1690.4%
RH$6.77M37,7910.4%
VIEMED HEALTHCARE, INC.VMDCommon Stock$6.93M932,4450.4%
HAIN CELESTIAL GROUP INC$6.99M6,528,7890.4%
Reservoir Media, Inc.RSVRCommon Stock$7.12M940,9600.4%
Keros Therapeutics, Inc.$7.34M360,4190.4%
COLUMBUS MCKINNON CORP$7.76M450,0000.5%
Integer Holdings Corp$8.00M102,0000.5%
Inhibikase Therapeutics, Inc.$8.06M3,929,2920.5%
eHealth, Inc.$8.10M1,761,4410.5%
Cogent Biosciences, Inc.$8.88M250,0000.5%
QUINCE THERAPEUTICS INC$8.95M2,672,4290.5%
Distribution Solutions Group, Inc.DSGRCommon Stock$9.04M330,0000.5%
Solid Biosciences Inc.SLDBCommon Stock$9.04M1,603,3360.5%
Industrial Logistics Properties TrustILPTREIT$9.30M1,678,9730.6%
PATHWARD FINANCIAL INC$9.34M131,6080.6%
Silence Therapeutics plcSLNADR$9.38M1,542,4270.6%
Opus Genetics, Inc.$9.61M4,781,3300.6%
X4 Pharmaceuticals, Inc$9.80M2,449,4680.6%
Lexeo Therapeutics, Inc.$9.93M1,000,0000.6%
NEW ROYAL HOLDCO I INC.$10.01M368,2450.6%
PepGen Inc.$10.07M1,547,2290.6%
Amylyx Pharmaceuticals, Inc.$10.10M835,6840.6%
Camping World Holdings, Inc.$10.30M1,058,5420.6%
Disc Medicine, Inc.IRONCommon Stock$10.55M132,8000.6%
BIOCRYST PHARMACEUTICALS INC$10.58M1,356,3770.6%
RAYONIER ADVANCED MATERIALS INC.$10.60M1,800,0000.6%
HERBALIFE LTD$11.37M881,8570.7%
USANA HEALTH SCIENCES INC$11.49M585,0740.7%
Aura Biosciences, Inc.AURACommon Stock$11.54M2,117,6970.7%
GERON CORP$11.91M9,025,0000.7%
Anteris Technologies Global Corp.$12.63M2,530,9100.8%
Service Properties Trust$12.99M7,057,8870.8%
1-800-Flowers.com Inc$13.26M3,375,0650.8%
JEFFERSON CAPITAL, INC.JCAPCommon Stock$13.40M600,0000.8%
Upstream Bio, Inc.UPBCommon Stock$13.44M494,9710.8%
Apyx Medical CorpAPYXCommon Stock$13.91M3,974,0910.8%
Benitec Biopharma Inc.BNTCCommon Stock$13.99M1,038,3710.8%
ASTRIA THERAPEUTICS INC$14.00M1,069,5300.8%
TriSalus Life Sciences, Inc.$14.45M2,070,8270.9%
LB PHARMACEUTICALS INCLBRXCommon Stock$15.03M675,0000.9%
Dianthus Therapeutics, Inc.$15.45M375,0000.9%
ZEVRA THERAPEUTICS, INC.$15.88M1,771,9360.9%
← PrevPage 2 of 3Next →